The 6th Drug Safety Symposium 2026 - India Chapter, scheduled for June 24th & 25th, 2026 in Mumbai, will bring together leading voices from across the pharmacovigilance ecosystem to address one of the industry’s most pressing questions
The Shigella threat in Kerala continues to grow as the state reported one more death linked to the infection along with seven fresh cases from multiple districts.
Himachal Pradesh invests Rs 150 crore in diagnostics as the state government moves to strengthen healthcare infrastructure across the state.
Aurobindo Pharma has moved a step closer to completing its USD 250 million acquisition of Lannett Company after receiving approval from the US Federal Trade Commission (FTC).
Sun Pharma’s latest acquisition marks another strategic step in its efforts to strengthen its presence beyond traditional pharmaceuticals.
Sun Pharma recall has once again brought attention to drug manufacturing standards and regulatory compliance in the United States.
.jpeg "Are Generic Cancer Drugs Driving India Pharma Growth?")
India’s generic cancer drug market is expanding with improved affordability, innovation, and access, as companies like Alembic advance complex oncology generics globally.
Gujarat’s Sickle Cell Mission has emerged as one of India’s most successful public health initiatives, with the state crossing 1.11 crore screenings for sickle cell disease.
The Centre's latest Dengue Preparedness Review comes at a crucial time as the monsoon season approaches and the risk of mosquito-borne diseases begins to rise across the country.
India’s HPV campaign has reached a major milestone, with nearly 50 lakh girls vaccinated within just three months of the nationwide rollout.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")